Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Protea Wins R&D 100 Award

By Drug Discovery Trends Editor | July 10, 2012

Protea Biosciences Group Inc., a leading developer of technologies and services for biomolecular analysis, announced that its LAESI DP-1000 direct ionization system has been selected by an independent judging panel and the editors of R&D Magazine to receive a 2012 R&D 100 Award. The LAESI DP-1000 was hailed by R&D Magazine as one of the 100 most technologically significant products introduced in the past year.

The LAESI DP-1000 is the first instrument to allow the direct identification and mass spectrometric profiling of biomolecules in vivo with rapid analysis completed in seconds to minutes, and does not require sample preparation.

“We thank the judges and editors of R&D Magazine for their recognition of our LAESI DP-1000 instrument,” said Stephen Turner, Protea’s Chief Executive Officer. “LAESI is a universal platform, one that can be used to rapidly identify the biomolecules present in all types of biological samples, including tissue biopsies, live cells, blood, and even plants, water and forensic samples. LAESI DP-1000 allows the direct, molecular analysis of living cells, so that changes that occur over time can be identified and tracked. We believe this breakthrough will be of great benefit for advancing pharmaceutical and medical research.”

LAESI technology was invented in the laboratory of Akos Vertes, Ph.D., George Washington University (GWU), and is exclusively licensed to Protea. Dr. Vertes stated, “The delicate balance of diverse biochemical reactions is at the core of keeping an organism alive and well. By providing a detailed look at the molecular composition of complex biological systems, LAESI enables a deeper understanding of health and disease. This technology has the potential to transform medical diagnoses, treatment monitoring, and the prognosis for recovery. The exemplary collaboration between the GWU and Protea teams has resulted in a rapid translation of the original laboratory discovery into a powerful commercial instrument.”

The R&D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing, and biotechnology.

Since its founding in 1959 as Industrial Research, R&D Magazine has served research scientists, engineers and technical staff at laboratories around the world, providing timely, informative news and useful technical articles that broaden readers’ knowledge of the research and development industry and improve the quality of their work.

Date: June 21, 2012
Source: Protea Biosciences Group Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
Dupixent approved to treat bullous pemphigoid
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE